Zscaler, Inc.
Zscaler, Inc. (ZS) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Zscaler, Inc. (ZS), featuring income statements, balance sheets, and cash flow data.
Zscaler, Inc. (ZS) Income Statement & Financial Overview
Analyze Zscaler, Inc.’s ZS earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $647.90M | $627.96M | $592.87M | $553.20M |
| Cost of Revenue | $148.50M | $141.46M | $130.21M | $119.10M |
| Gross Profit | $499.40M | $486.49M | $462.66M | $434.10M |
| Gross Profit Ratio | $0.77 | $0.77 | $0.78 | $0.78 |
| R&D Expenses | $170.86M | $154.25M | $139.15M | $125.02M |
| SG&A Expenses | $368.26M | $362.91M | $350.46M | $313.51M |
| Operating Expenses | $539.54M | $517.16M | $489.61M | $438.52M |
| Total Costs & Expenses | $688.04M | $658.62M | $619.82M | $557.62M |
| Interest Income | $30.88M | $30.05M | $27.23M | $27.57M |
| Interest Expense | $1.36M | $3.14M | $3.60M | $2.76M |
| Depreciation & Amortization | $28.73M | $25.66M | $24.40M | $21.05M |
| EBITDA | $13.55M | $24.39M | $23.03M | $44.30M |
| EBITDA Ratio | $0.02 | $0.04 | $0.04 | $0.08 |
| Operating Income | -$40.14M | -$30.67M | -$26.95M | -$4.42M |
| Operating Income Ratio | -$0.06 | -$0.05 | -$0.05 | -$0.008 |
| Other Income/Expenses (Net) | $23.60M | $26.25M | $21.85M | $23.88M |
| Income Before Tax | -$16.54M | -$4.41M | -$5.10M | $20.87M |
| Income Before Tax Ratio | -$0.03 | -$0.007 | -$0.009 | $0.04 |
| Income Tax Expense | -$8.81M | $7.64M | $9.77M | $1.74M |
| Net Income | -$7.72M | -$12.05M | -$14.88M | $19.12M |
| Net Income Ratio | -$0.01 | -$0.02 | -$0.03 | $0.03 |
| EPS | -$0.05 | -$0.08 | -$0.10 | $0.13 |
| Diluted EPS | -$0.05 | -$0.08 | -$0.10 | $0.12 |
| Weighted Avg Shares Outstanding | $153.67M | $152.56M | $149.59M | $150.29M |
| Weighted Avg Shares Outstanding (Diluted) | $153.67M | $152.56M | $151.50M | $154.08M |
Over the past four quarters, Zscaler, Inc. demonstrated steady revenue growth, increasing from $553.20M in Q3 2024 to $647.90M in Q2 2025. Operating income reached -$40.14M in Q2 2025, maintaining a consistent -6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $13.55M, reflecting operational efficiency. Net income rose to -$7.72M, with EPS at -$0.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan